Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

BioExx Specialty Proteins Ltd BIXZF

"Bioexx Specialty Proteins Inc is engaged in the development and commercialization of processing technologies, for use in the extracting various active ingredients from organic and inorganic materials. The company's primary focus is on the production of proteins from canola and other oilseed feedstocks. Its products include Isolexx, a protein isolate for use in bakery products, meat products, vegetarian food products and meat analogues, and nutritional and protein bars, drinks, and supplements;


GREY:BIXZF - Post by User

Comment by gadfly222on Dec 11, 2012 8:36pm
306 Views
Post# 20716380

RE: RE: RE: EFSA

RE: RE: RE: EFSA

1320racing - I was just thinking about the timing of the EU Food Safety Registration process ... hearing about it soon would be a good thing...

EU Food Safety Registration Update

Recently, the Food Safety Authority of Ireland (FSAI) completed and submitted to the European Commission its initial assessment of BioExx rapeseed protein (Isolexx®) as a novel food ingredient for use in EU in the same general food types that currently contain soya protein and at equivalent levels. To that end, the FSAI identified no food safety concerns, and therefore Isolexx is considered to meet the criteria for novel food set out in EU regulations. This assessment and application was sent to all EU Member States at the outset of October for a two month review and the opportunity to request clarification if reasoned objection exists. If at the end of the two months there are no questions/objections, Isolexx will then be authorized for sale and use throughout Europe. BioExx intends to follow that registration with a similar registration for its Vitalexx® hydrolized protein in Europe. The EU novel food registration would be in addition to the current and existing FDA GRAS approved status for the sale of BioExx proteins in the United States.

<< Previous
Bullboard Posts
Next >>